Newbury Pharmaceuticals ABNEWBRY 
$0.340.58%24h
0.58%24h
Global rank33988
Market cap$6.64M
Change 7d-2.81%
YTD Performance10.19%
SP500 benchmarkUnderperform
P/E-0.34
P/S6.58
Revenue$1.01M
Earnings-$1.91M
Dividend yield-
Main Sector
Healthcare
Newbury Pharmaceuticals AB Revenue data
According to Newbury Pharmaceuticals AB latest financial reports the company had revenue of $1.01M in 2023-08-31, a 86.11% increase from 2022. Newbury Pharmaceuticals AB highest revenue was $1.01M in 2023.
Revenue history for Newbury Pharmaceuticals AB from 2021 to 2024
-
Value:-
Newbury Pharmaceuticals AB revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $1.01M | 86.11% |
| 2022 | $541.87K | 94.98% |
| 2021 | $277.91K | - |
View the top revenue stocks 
